Cargando…
Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323704/ https://www.ncbi.nlm.nih.gov/pubmed/33433482 http://dx.doi.org/10.4103/1673-5374.303027 |
_version_ | 1783731295597101056 |
---|---|
author | Zhang, Jie Jasutkar, Hilary Grosso Mouradian, M. Maral |
author_facet | Zhang, Jie Jasutkar, Hilary Grosso Mouradian, M. Maral |
author_sort | Zhang, Jie |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8323704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-83237042021-08-11 Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies Zhang, Jie Jasutkar, Hilary Grosso Mouradian, M. Maral Neural Regen Res Perspective Wolters Kluwer - Medknow 2021-01-07 /pmc/articles/PMC8323704/ /pubmed/33433482 http://dx.doi.org/10.4103/1673-5374.303027 Text en Copyright: © 2021 Neural Regeneration Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Perspective Zhang, Jie Jasutkar, Hilary Grosso Mouradian, M. Maral Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies |
title | Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies |
title_full | Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies |
title_fullStr | Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies |
title_full_unstemmed | Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies |
title_short | Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies |
title_sort | targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323704/ https://www.ncbi.nlm.nih.gov/pubmed/33433482 http://dx.doi.org/10.4103/1673-5374.303027 |
work_keys_str_mv | AT zhangjie targetingtransglutaminase2asapotentialdiseasemodifyingtherapeuticstrategyforsynucleinopathies AT jasutkarhilarygrosso targetingtransglutaminase2asapotentialdiseasemodifyingtherapeuticstrategyforsynucleinopathies AT mouradianmmaral targetingtransglutaminase2asapotentialdiseasemodifyingtherapeuticstrategyforsynucleinopathies |